Following initial safety (Phase I) testing, a drug is tested for efficacy, typically in blind, randomized trials, in which a control group receives a placebo. Phase II testing may last from several months to two years. Phase II trials involve 100-300… Read More »
Abbott achieved positive results from a Phase II dose-ranging study of atrasentan, a highly selective endothelin A receptor antagonist in development to help slow chronic kidney disease (CKD) progression in patients with type 2 diabetic kidney disease. Read More »
Althea Technologies, Inc. has been selected by GeoVax Labs, Inc., an Atlanta-based biotechnology company, to manufacture its HIV-1 DNA (AIDS) vaccine for GeoVax’s Phase II trials, expected to begin in early 2008.
GeoVax AIDS vaccines ar… Read More »
Kendle will acquire the Phase II-IV Clinical Services business of Charles River Laboratories International, Inc. for approximately $215 million in cash. The move will strengthen Kendle's position in the clinical development industry, adding therapeut… Read More »